View all adult cancer types
View all pediatric cancer types
Susan F. Smith Center for Women's Cancers
Gynecologic CancerBlood CancersCancer Genetics and PreventionCutaneous (Skin) CancerGastrointestinal CancerGenitourinary CancerHead and Neck CancerHematologyMelanomaNeuro-OncologySarcomaStem Cell TransplantThoracic (Lung) Cancer
Blood DisordersBrain TumorsHematologic MalignanciesSolid TumorsStem Cell Transplant
Dana-Farber Cancer Institute has launched DiscoverCareBelieve.org, a new platform to illustrate what sets Dana-Farber apart — in research discovery... in expert, compassionate care... and in our strong belief in progress for people with cancer everywhere.WebsiteVideoWhat do you #DiscoverCareBelieve?
First study of the genomic composition of prostate cancer shows many patients have gene mutations that can be targeted with existing or potential drugs.
Clinicians at Dana-Farber/Brigham and Women'’s Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.
A new technology developed at Dana-Farber may make it possible to target "undruggable" proteins and overcome drug resistance by using a cancer cell's own protein-degrading machinery to destroy, not just inhibit, cancer proteins.
Dana-Farber/Brigham and Women's Cancer Center has a new website to connect patients and physicians with information about precision cancer medicine, including resources on what precision cancer is and how it can be applied to cancer care today.
Dana-Farber's Levi Garraway, MD, PhD, has been selected as one of 26 Howard Hughes Medical Institute investigators.
Dr. Jonathan Marron led a study that found it's better for
doctors to be open with parents about their child's cancer prognosis, even if
the news is bad.
Dr. Lawrence Shulman discussed his work in both Rwanda and
Haiti, by providing access to life-saving advances in cancer treatment.
Tom Brokaw discussed his life after being diagnosed with multiple myeloma and cites Dr. Ken Anderson for being both a respected clinician and friend.
Dipanjan Chowdhury, PhD, led a study showing a new blood test that could quickly reveal the severity of radiation injury.
Dr. Harold Burstein commented on the increase in women
opting to undergo preventive bilateral mastectomies.
Dr. Pasi Jänne led a study that showed a drug shrank lung tumors in 61 percent of patients whose cancers had developed the T790-M resistance mutation. He also commented on personalized medicine for cancer patients.
Dr. Philip Kantoff and Dr. Lauren Harshman led a study that found hormone-sensitive prostate cancer patients who started on cholesterol-lowering statin drugs at initiation of androgen-deprivation therapy experienced a longer time to disease progression.
10:00 AM - 11:30 AM
DA110 - Dana Bldg., 1st Floor, Room DA110
Fine tune your mind/body skills and create balance among them. Open to patients and family members. Please register at 617-632-3322.
Tai Chi for Optimal Health with Ramel Rones
11:30 AM - 1:00 PM
An Internal Chinese martial art practiced for both defense training and health benefits. Learn sitting and standing techniques as well as slow moving meditation. Open to patients and family members. For more information or to register, please contact the Zakim Center at 617-632-3322 or Zakim_Center@dfci.harvard.edu.
2:00 PM - 3:00 PM
Connect to your breath, body, and joy through group singing. Discover how group singing can support relaxation, mood, sense of community, and pain management. Lyrics will be provided. Song requests and discussion are welcome, and no prior music experience is required.
To register please call 617-692-3322 or email: Zakim_Center@dfci.harvard.edu.
Patient referral information, clinical resources and more.
For adults:877-442-3324Quick access: Appointments as soon as the next day for new adult patientsFor children:888-733-4662
Search current cancer clinical trials at Dana-Farber.
There are many ways to support Dana-Farber and the Jimmy Fund.
Top-ranked cancer center in New England for adults (with Brigham and Women's Hospital) — #1 in the nation for children (with Boston Children's Hospital)
Insight features the latest in cancer care and research news from Dana-Farber.Read the blog
Stay current on the latest news by signing up for Spotlight, our email newsletter.View current issueSubscribe now
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: